Optimizing the “Drug-Like” Properties of Leads in Drug Discovery
Drug discovery and development is a very complex, costly, and ti- consuming process. Because of the uncertainties associated with predicting the pharmacological effects and the toxicity characteristics of new chemical entities in man, their clinical development is quite prone to failure. In recent y...
| Corporate Author: | SpringerLink (Online service) |
|---|---|
| Other Authors: | Borchardt, Ronald T. (Editor), Kerns, Edward H. (Editor), Hageman, Michael J. (Editor), Thakker, Dhiren R. (Editor), Stevens, James L. (Editor) |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
New York, NY :
Springer New York,
2006.
|
| Series: | Biotechnology: Pharmaceutical Aspects ;
IV |
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
Similar Items
-
Drug Discovery and Evaluation Safety and Pharmacokinetic Assays /
Published: (2006) -
The Science and Business of Drug Discovery Demystifying the Jargon /
by: Zanders, Edward D.
Published: (2011) -
Drug Discovery and Evaluation Pharmacological Assays /
Published: (2008) -
Drug Discovery and Evaluation: Methods in Clinical Pharmacology
Published: (2011) -
Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
Published: (2013)